Estrella Immunopharma (ESLA) Live Share Price, Invest From India

Estrella Immunopharma Stock Performance

as on October 3, 2026 at 2:16 pm IST

Day's Low
Day's High
$0.46
Day's Price Range
$0.51
$0.47
1.71%
Downside
8.97%
Upside
52 Week's Low
52 Week's High
$0.43
52-Week Price Range
$3.15
$0.47
7.84%
Downside
573.08%
Upside

Estrella Immunopharma share price movements today

Previous Close: $0.48
Open: $0.47
Volume: 46.4K
Market Cap: $20.7M
Day's Low - High: $0.46 - $0.51
52 Week Low - High: $0.43 - $3.15

Estrella Immunopharma Historical Returns

1 Month Return: -26.99 %
3 Month Return: -52.37 %
1 Year Return: -64.27 %
3 Year Return: -83.58 %
5 Year Return: 0 %

Estrella Immunopharma Stock Fundamentals & Key Indicators

Check Estrella Immunopharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$20.7M

EPS (TTM)

-0.2462

Dividend Yield

0.00%

PE Ratio (TTM)

-1.87

Industry PE ratio

-2.27

PEG Ratio

-0.10

Return On Equity TTM

121.72%

Estrella Immunopharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Estrella Immunopharma with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Estrella Immunopharma	NA	$20.7M	NA	-1.87	0.00%	0.00%
Revolution Medicines	StrongBuy	$44.1B	609.62%	-23.34	0.00%	0.00%
Moderna	Neutral	$75.4B	-44.29%	-24.08	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$132.5B	180.98%	30.19	86.04%	0.00%
Regeneron	Buy	$78.1B	28.80%	17.67	84.86%	0.50%

Stock Returns calculator for Estrella Immunopharma Stock including INR - Dollar returns

The Estrella Immunopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Estrella Immunopharma investment value today

Current value as on today

₹38,777

Returns

-₹61,223

(-61.22%)

Returns from Estrella Immunopharma Stock

-₹64,275 (-64.27%)

Dollar Impact

₹3,052 (+3.05%)

Indian Investors' Interest in Estrella Immunopharma Stock

Search interest for Estrella Immunopharma Stock has increased by 260% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 4, 2026 to October 4, 2026

Change:260% versus previous 30 day period

Estrella Immunopharma Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	0	-3	-3	-1	-2	-5	-4	0	-2	-2
EBITDA	0	-3	-3	-1	-2	-5	-4	0	-2	-2
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	0	-3	-3	-1	-2	-5	-4	0	-2	-2
Income Tax Expense	-	0	-	0	0	0	-	0	-	-
Net Income	0	-3	-3	-1	-2	-5	-4	0	-2	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Estrella Immunopharma Annual Profit & Loss

All numbers in Millions USD

	Jun 2021	Jun 2022	Dec 2022	Jun 2024	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Income	0	-1	-11	-7	-8	-13
EBITDA	0	-1	-11	-7	-8	-13
Interest Expense	-	-	-	-	-	-
Depreciation	0	-	-	-	-	-
Income Before Tax	0	-1	-11	-7	-8	-13
Income Tax Expense	-	-	-	0	0	0
Net Income	0	-1	-11	-7	-8	-13
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Estrella Immunopharma Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	0	-3	-3	-1	-2	-5	-4	0	-2	-2
Operating Cash Flow	-15	0	-2	0	0	0	0	0	-6	-1
Investing Cash Flow	4	-	-	-	-	-	-	-	-	-
Financing Cash Flow	13	0	0	0	0	1	1	0	7	0
Change in Cash	4	0	-2	0	0	0	0	0	0	-1

Estrella Immunopharma Annual Cash Flow

All numbers in Millions USD

	Jun 2021	Jun 2022	Dec 2022	Jun 2024	Dec 2024	Dec 2025
Net Income	0	-1	0	-7	-8	-13
Operating Cash Flow	0	-1	-1	-16	-3	-1
Investing Cash Flow	-	-	36	4	-	-
Financing Cash Flow	0	5	-35	12	0	2
Change in Cash	-	4	0	1	0	0

Global Institutional Holdings in Estrella Immunopharma

Check out the Institutions with significant holdings in Estrella Immunopharma.

Funds	Holdings
Vanguard	0.96%
VANGUARD INDEX FUNDS	0.88%
Fidelity Concord Street Trust	0.22%
iShares	0.11%

Insights on Estrella Immunopharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 82.2% return, outperforming this stock by 166.3%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 631.2%
NEGATIVE IMPACT
Price Dip
In the last 1 month, ESLA stock has moved down by -27.6%

About Estrella Immunopharma

Estrella Immunopharma, Inc. is an early-stage biopharmaceutical enterprise focused on creating T-cell therapies for various blood cancers and solid tumors, with its primary activities centered in the United States. The company's lead investigational drugs include EB103, which is in preclinical development for diffuse large B-cell lymphoma, and EB104, intended for the treatment of both diffuse large B-cell lymphoma and acute lymphocytic leukemia. Estrella also maintains a collaborative agreement with Imugene Limited, working together to develop solid tumor therapies that integrate Imugene's CF33-CD19t product candidate with Estrella's EB103. The company is based in Emeryville, California.

Organisation	Estrella Immunopharma
Headquarters	5858 Horton Street, EmeryVille, CA, 94608, US
Industry	Biotechnology
CEO	Cheng Liu

Key Management of Estrella Immunopharma

Name	Title
Dr. Cheng Liu Ph.D.	CEO, President & Director
Mr. Jiandong Xu	Chief Financial Officer

FAQs

What is Estrella Immunopharma share price today?

Estrella Immunopharma share price today is $0.47 as on October 3, 2026 at 8:46 am IST at the close of the market. Estrella Immunopharma share today touched a day high of $0.51 and a low of $0.46.

What is the 52 week high and 52 week low for Estrella Immunopharma share?

Estrella Immunopharma share touched a 52 week high of $3.15 on November 4, 2025 and a 52 week low of $0.43 on September 28, 2026. Estrella Immunopharma stock price today i.e. October 3, 2026 at 8:46 am IST is closed at $0.47,which is 85.14% down from its 52 week high and 8.51% up from its 52 week low.

What is Estrella Immunopharma's market capitalisation today?

Estrella Immunopharma market capitalisation is $0.00T as on October 3, 2026 at 8:46 am IST.

How to invest in Estrella Immunopharma Stock (ESLA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Estrella Immunopharma on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Estrella Immunopharma Stock (ESLA) from India?

Indian investors can start investing in Estrella Immunopharma (ESLA) shares with as little as ₹96.300003051758 or $1 (as of October 4, 2026 at 8:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Estrella Immunopharma stock (as per the Rupee-Dollar exchange rate as on October 4, 2026 at 8:40 pm IST). Based on Estrella Immunopharma share’s latest price of $0.47 as on October 3, 2026 at 8:46 am IST, you will get 21.3675 shares of Estrella Immunopharma. Learn more about fractional shares .